Tag: Agamree

Explore our medication guides and pharmacology articles within this category.

What Is the Steroid Equivalent of Vamorolone? A Comparative Look at a Novel Corticosteroid

Oct 8, 2025 •

4 min read

Approved by the FDA in 2023 for Duchenne muscular dystrophy, vamorolone represents a new class of corticosteroids with a modified mechanism of action. This innovation prompts the critical question: what is the steroid equivalent of vamorolone, and how does it fundamentally differ from traditional steroids like prednisone?

What type of drug is vamorolone? A Look at Dissociative Steroids

Oct 6, 2025 •

4 min read

In October 2023, the U.S. Food and Drug Administration (FDA) approved vamorolone (brand name Agamree) for the treatment of Duchenne muscular dystrophy (DMD), signaling a new approach in steroid therapy. This first-in-class drug is a novel dissociative corticosteroid, designed to retain the therapeutic benefits of traditional steroids while minimizing common adverse side effects.